ADSX Applied Digital Solutions (MM)

DELRAY BEACH, Fla., March 2 /PRNewswire-FirstCall/ -- VeriChip Corporation ("VeriChip" or the "Company") (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, announced today that it will reschedule the release of its fourth quarter and full year financial results for the period ended December 31, 2006, from Monday, March 5, 2007 to Thursday, March 8, 2007, as a result of the 25-day post-effective period following the commencement of its recent initial public offering. The Company now plans to issue its fourth quarter and full year financial results on Thursday, March 8, 2007 at 7:30 a.m. ET. That same day, the Company will hold a conference call to discuss the results. The conference call will take place at 8:30 a.m. EST. Interested participants should call (800) 472-8309 within the United States or (706) 643- 9561 internationally. Please use passcode 1338987. The playback of the conference will be available two hours after the completion of the call for 30 days. To listen to the playback, please call (800) 642-1687 within the United States or (706) 645-9291 internationally. Please use passcode 1338987. The call will also be webcast and will be available on the home page of the Company's web site at http://www.verichipcorp.com/. About VeriChip Corporation VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration. VeriChip Corporation is majority-owned by Applied Digital Inc. (NASDAQ:ADSX), which also owns a majority position in Digital Angel Corporation (AMEX:DOC). For more information on VeriChip, please call 1-800- 970-2447, or email . Additional information can be found online at http://www.verichipcorp.com/. Certain statements herein are "forward-looking statements". Such forward- looking statements are not historical facts but instead reflect VeriChip's current expectations or beliefs concerning future events and results of operations, many of which, by their nature, are inherently uncertain and outside of VeriChip's control. It is possible that actual results may differ, possibly materially, from those anticipated in these forward-looking statements. For a discussion of some of the risks and important factors that could affect future events and results of operations, see the discussion in our Registration Statement on Form S-1 (Commission file number 333-130754) under the caption "Risk Factors." VeriChip does not undertake to publicly update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. Contact: VeriChip Corporation The Ruth Group Allison Tomek Nick Laudico (investors) 561-805-8000 (646) 536-7030 Jason Rando (media) (646) 536-7025 DATASOURCE: VeriChip Corporation CONTACT: Allison Tomek of VeriChip Corporation, +1-561-805-8000, ; or Investors: Nick Laudico, +1-646-536-7030, , or Media: Jason Rando, +1-646-536-7025, , both of The Ruth Group, for VeriChip Corporation Web site: http://www.verichipcorp.com/

Copyright